about
RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patientsRandomized controlled trial demonstrates the benefit of RGTA® based matrix therapy to treat tendinopathies in racing horses.ReGeneraTing Agents (RGTA) are a new option to improve amputation outcomes in the recovery of severe hand injuriesReGeneraTing Agents (RGTA): A new option for healing and improving treatment outcomes for traumatic and burn injuries of the hand
P50
description
researcher
@en
wetenschapper
@nl
name
Denis Barritault
@en
Denis Barritault
@nl
type
label
Denis Barritault
@en
Denis Barritault
@nl
prefLabel
Denis Barritault
@en
Denis Barritault
@nl
P31
P496
0000-0003-0315-7444